Skip to main content
Nigel Key, MD, Hematology, Chapel Hill, NC, University of North Carolina Hospitals

NigelSKeyMD

Hematology • Chapel Hill, NC

Professor, Medicine, University of North Carolina at Chapel Hill School of Medicine

Join to view full profile

Dr. Key is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Key's full profile

Already have an account?

Summary

  • Dr. Nigel Key is a hematologist in Chapel Hill, NC and is affiliated with University of North Carolina Hospitals. He received his medical degree from University of Manchester Faculty of Medicine and has been in practice 36 years. He is experienced in thrombotic disorders, general / benign hematology, and transfusion medicine.

Education & Training

  • University of Minnesota
    University of MinnesotaFellowship, Hematology and Medical Oncology, 1988 - 1990
  • University of Manchester Faculty of Medicine
    University of Manchester Faculty of MedicineClass of 1981

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 2009 - 2024
  • MN State Medical License
    MN State Medical License 1990 - 2018

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Newsworthy from the School of Medicine, Week of July 22 – July 28
    Newsworthy from the School of Medicine, Week of July 22 – July 28July 27th, 2022
  • Gene Therapy Reduced Risk of Excessive Bleeding for People with Hemophilia B, Early Trial Data Suggests
    Gene Therapy Reduced Risk of Excessive Bleeding for People with Hemophilia B, Early Trial Data SuggestsJuly 22nd, 2022
  • Data from Spain Yield New Insights on a Rare Hemophilia
    Data from Spain Yield New Insights on a Rare HemophiliaNovember 2nd, 2021
  • Join now to see all

Grant Support

  • Mechanisms Of Venous Thromboembolism In CancerNational Heart, Lung, And Blood Institute2008–2012
  • Research Fellowships In Hematology/OncologyNational Heart, Lung, And Blood Institute2005–2011
  • Rituximab For The Treatment Of Inhibitors In Congenital Hemophilia ANational Center For Research Resources2008
  • PREVENT: Prevention Of Recurrent Venous ThromboembolismNational Center For Research Resources2004
  • Catheter Directed Thrombolytic Therapy In Deep Vein ThrombosisNational Center For Research Resources2004
  • New Therapies For HemophiliaNational Heart, Lung, And Blood Institute2000–2004
  • Tissue Factor In HemophiliaNational Heart, Lung, And Blood Institute2000–2002
  • PREVENT: Prevention Of Recurrent Venous ThromboembolismNational Center For Research Resources2000–2002
  • Endothelial Cells In HomocystinuriaNational Center For Research Resources2000–2002
  • Mechanisms Of Thrombosis In Sickle DiseaseNational Heart, Lung, And Blood Institute1995–1998
  • The Role Of The Neutrophil In Inflammatory ThrombosisNational Heart, Lung, And Blood Institute1990–1991

Hospital Affiliations

Dr. Nigel Key, Dr. Nigel Key, MD, Dr. N Key, Dr. Nigel S Key